SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
CVTX - CV Therapeutics, Inc.
An SI Board Since January 1999
Posts SubjectMarks Bans
411 31 0
Emcee:  Todd N. Weisrock Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
186Piper reports that SHR is going to test higher doses in hopes of improving efficmopgcw-3/10/2004
185emphasis mine, for ACC..... Abstract Title: Initial Results Regarding the Safetscaram(o)uche-3/3/2004
1847:10AM CV Therapeutics files $300 mln mixed shelf, announces offering of 1.6 mlnmopgcw-2/27/2004
183CV Therapeutics Announces Five Abstracts Accepted for Presentation at American Cmopgcw-2/24/2004
182Masters Cap Cuts CV Therapeutics Stake To 1.3% DOW JONES NEWSWIRES WASHINGTON mopgcw-2/11/2004
181CV Therapeutics Reports Fourth Quarter and Year End Financial Results for 2003 Tmopgcw-2/11/2004
180CVTX: Sells $10 Million in Common Stock to Acqua Wellington According to mopgcw-2/2/2004
179" CV has yet to make money, but if Ranexa is approved, it could be a home rMiljenko Zuanic-1/22/2004
178CV Investors: Take Heart "Alluringly Cheap" Lately, CV TherapeuticsDoc Bones-1/22/2004
17717:39 Business Week comments on CVTX According to BusinessWeek, CV TherapeutDoc Bones-1/22/2004
176JAMA Publishes Data on Effect of Ranexa(TM) on Key Markers of Angina Severity inmopgcw-1/20/2004
175Bioorg Med Chem Lett. 2004 Jan;14(2):535-539. Affinity and intrinsic efficacyscaram(o)uche-12/31/2003
174GREER R SCOTT,DIRECTOR,BUYS 10,000 ON 12/12/03 OF CV THERAPEUTIC 2003-12-15 22:1mopgcw-12/16/2003
173Have you considered the possibility that Ranexa failure, complete, is in the stoscaram(o)uche-12/15/2003
172Is there any truth to the story that CVTX's major partner in developing/sellKeepItSimple-12/15/2003
171CVTX to present at CV Therapeutics at JPMorgan 22nd Annual Healthcare San Francmopgcw-12/11/2003
170Piper goes out on a limb and recommends buying here given the positive panel revmopgcw-12/11/2003
169Yes, a boat load @ $12.50. There were a couple thousand I saw that went off firmopgcw-12/10/2003
168In the "No S***" Category w/ 1st Albany: CV Therapeutics Cut to `Unmopgcw-12/10/2003
1678:07 to 8:09 a.m., many, many thousands of shares........ quotes.nasdaq.com edscaram(o)uche-12/10/2003
166Just after 8 a.m., Eastern? I don't remember the exact number of shares goiscaram(o)uche-12/10/2003
165I saw the $10/$11, tried to buy some, but only about 5,000 shares traded there, mopgcw-12/10/2003
164CV Therapeutics Shares Rise Despite Angina Drug's Stumble Dow Jones, Wemopgcw-12/10/2003
163ah, shucks, you've got all the answers.scaram(o)uche-12/10/2003
162cash is meaningless since they're burning through that cash quickly..KeepItSimple-12/10/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News